Skip to NavigationSkip to content

coronavirus vaccine

Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials

U.S. Air Force photo by Staff Sgt. J.D. Strong II

Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New Drug program. The research has been partly funded by The Bill and Melinda Gates Foundation.

The FDA approval comes after promising results in animal testing. The INO-4800 DNA vaccine began being used in trials on Monday, with 40 volunteers receiving their first dose, which will be followed by a second in four weeks’ time.

Johnson & Johnson selects lead COVID-19 vaccine candidate and targets September Phase I study

Photo by Open Grid Scheduler

Johnson & Johnson announced that it has selected a candidate for a COVID-19 vaccine from potential constructs it has been investigating since January, and is targeting a Phase 1 study for September.

Paul Stoffels, Chief Scientific Officer at the company, said: “Supported by the global production capability that we are scaling up in parallel to this testing, we expect a vaccine could be ready for emergency use in early 2021.”

Sanofi agrees a second partnership to develop a COVID-19 vaccine


Sanofi has partnered with Translate Bio to develop a novel messenger RNA (mRNA) vaccine for COVID-19 while they are also leading trials outside the US for testing Kevzara in coronavirus patients.

Previously, Sanofi Pasteur, the company’s vaccine business, and Translate had been collaborating on creating five mRNA vaccines for infectious diseases. Translate will use its mRNA platform to discover, design and manufacture the vaccine while Sanofi will aim to use it resources to advance any potential vaccine found on this platform through the developmental stages.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches